Literature DB >> 7729305

Prospective study of lipoprotein(a) as a risk factor for atherosclerotic cardiovascular disease in patients with diabetes.

T Hiraga1, T Kobayashi, M Okubo, K Nakanishi, T Sugimoto, Y Ohashi, T Murase.   

Abstract

OBJECTIVE: To assess whether lipoprotein(a) [Lp(a)] is a risk factor for atherosclerotic cardiovascular disease in diabetes. RESEARCH DESIGN AND METHODS: We studied 221 patients with non-insulin-dependent diabetes mellitus (NIDDM) without diabetic complications who were followed for 2.2-3.1 years. Their serum Lp(a) levels were semiquantified by a rapid electrophoretic method that accurately discriminates high from low serum Lp(a) at the 20 mg/dl level.
RESULTS: Seven of 105 diabetic patients with a high serum Lp(a) experienced a clinical event related to atherosclerotic cardiovascular disease. This incidence was significantly higher than that of the 110 diabetic patients with a low serum Lp(a). The logistic regression analysis revealed that Lp(a) was an independent risk factor for the event.
CONCLUSIONS: Lp(a) is a significant risk factor for atherosclerotic cardiovascular disease in NIDDM.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7729305     DOI: 10.2337/diacare.18.2.241

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  18 in total

1.  Lipoprotein(a) predicts progression of carotid artery intima-media thickening in patients with type 2 diabetes: A four-year follow-up.

Authors:  Jozo Boras; Spomenka Ljubic; Nikica Car; Zeljko Metelko; Mladen Petrovecki; Marijana Vucic Lovrencic; Zeljko Reiner
Journal:  Wien Klin Wochenschr       Date:  2010-03       Impact factor: 1.704

2.  Lipoprotein profiles, not anthropometric measures, correlate with serum lipoprotein(a) values in children: the Taipei children heart study.

Authors:  N F Chu; L Makowski; J B Chang; D J Wang; S H Liou; S M Shieh
Journal:  Eur J Epidemiol       Date:  2000-01       Impact factor: 8.082

3.  Genetic variants, plasma lipoprotein(a) levels, and risk of cardiovascular morbidity and mortality among two prospective cohorts of type 2 diabetes.

Authors:  Qibin Qi; Tsegaselassie Workalemahu; Cuilin Zhang; Frank B Hu; Lu Qi
Journal:  Eur Heart J       Date:  2011-09-06       Impact factor: 29.983

4.  A prospective study of lipoprotein(a) and risk of coronary heart disease among women with type 2 diabetes.

Authors:  I Shai; M B Schulze; J E Manson; M J Stampfer; N Rifai; F B Hu
Journal:  Diabetologia       Date:  2005-06-22       Impact factor: 10.122

5.  Levels of Apolipoprotein A1, B100 and Lipoprotein (a) in Controlled and Uncontrolled Diabetic Patients and in Non-Diabetic Healthy People.

Authors:  Vishwal Indravadan Patel; Kinjal Prahaladbhai Patel; Mayur Goradhanbhai Makadia; Aashna Darshanbhai Shah; Kaushik Salubhai Chaudhari; Haridas Neelakandan Nilayangode
Journal:  J Clin Diagn Res       Date:  2017-02-01

6.  Lipoprotein(a) is related to the extent of lesions in the coronary vasculature and to unstable coronary syndromes.

Authors:  J D Zampoulakis; A A Kyriakousi; K A Poralis; N T Karaminas; I D Palermos; E T Chimonas; D V Cokkinos
Journal:  Clin Cardiol       Date:  2000-12       Impact factor: 2.882

7.  Lipoprotein(a) and risk of type 2 diabetes.

Authors:  Samia Mora; Pia R Kamstrup; Nader Rifai; Børge G Nordestgaard; Julie E Buring; Paul M Ridker
Journal:  Clin Chem       Date:  2010-05-28       Impact factor: 8.327

Review 8.  Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies.

Authors:  Christina Voulgari; Dimitrios Papadogiannis; Nicholas Tentolouris
Journal:  Vasc Health Risk Manag       Date:  2010-10-21

9.  Lipoprotein(a) and cardiovascular disease in diabetic patients.

Authors:  Qibin Qi; Lu Qi
Journal:  Clin Lipidol       Date:  2012-08

10.  Long-term lifestyle intervention lowers the incidence of stroke in Japanese patients with type 2 diabetes: a nationwide multicentre randomised controlled trial (the Japan Diabetes Complications Study).

Authors:  H Sone; S Tanaka; S Iimuro; S Tanaka; K Oida; Y Yamasaki; S Oikawa; S Ishibashi; S Katayama; H Yamashita; H Ito; Y Yoshimura; Y Ohashi; Y Akanuma; N Yamada
Journal:  Diabetologia       Date:  2010-01-07       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.